Citation Impact
Citing Papers
An update on the regulatory mechanisms of NLRP3 inflammasome activation
2021
The role of inflammasomes in kidney disease
2019
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Gut microbiome and health: mechanistic insights
2022 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
2017
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
2021
TLRs/NLRs: Shaping the landscape of host immunity
2017
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The gut microbiota at the intersection of diet and human health
2018 Science
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
2017
The Controversial Role of Human Gut Lachnospiraceae
2020 Standout
Works of Debora Collotta being referenced
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts
2021
Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways
2016
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study
2018
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades
2020